Aktie A2H9VK BLISS GVS PHARMA LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Bliss GVS Pharma Limited NSE India S.E.

Aktien

A2H9VK

INE416D01022

BLISSGVS

Markt geschlossen - NSE India S.E.
Andere Börsenplätze
 09:02:07 18.05.2024 		% 5 Tage % 1. Jan.
110,4 INR +0,96 % Intraday Chart für Bliss GVS Pharma Limited +0,41 % -11,43 %
02.05. Bliss GVS Pharma Limited berichtet über die Ergebnisse für das Geschäftsjahr zum 31. März 2024 CI
02.05. Bliss GVS Pharma Limited meldet die Ergebnisse für das vierte Quartal bis zum 31. März 2024 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
Bliss GVS Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Assistant Commission of State Tax Maharashtra, Mumbai Initiates Search At Certain Premises of Bliss GVS Pharma Limited
Bliss Gvs Pharma Limited Announces Change in the Designation of Mr. Vishal Vijay Rao
Bliss GVS Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Bliss GVS Pharma Limited Declares Final Dividend for the Financial Year Ended March 31, 2023
Bliss GVS Pharma Gets Establishment Inspection Report from US FDA for Palghar, India Unit
Bliss Gvs Pharma Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023
Bliss GVS Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
Bliss GVS Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Infomerics Keeps BBB Rating on Bliss GVS Pharma's Bank Financing; Outlook Stable
Bliss GVS Pharma Gets Three Observations from US FDA's Plant Inspection in Maharashtra, India
Bliss GVS Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Bliss GVS Pharma Names New CFO
Bliss GVS Pharma Limited Appoints Mr. Deepak Sawant as Chief Financial Officer
Bliss GVS Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Bliss GVS Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2H9VK Aktie
  4. A2H9VK Aktie
  5. Nachrichten Bliss GVS Pharma Limited
  6. Andere Sprachen